NYSE:HQL

Tekla Life Sciences Investors

Stock

USD

Last Close

16.06

06/11 21:10

Market Cap

397.95M

Beta: 0.83

Volume Today

105.41K

Avg: 77.50K

Dividend Yield

9.13%

Payout:62.47%

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Sep '15	Sep '16	Sep '17	Sep '18	Sep '19	Sep '20	Sep '21	Sep '22	Sep '23	Sep '24
revenue	1.32M -	1.44M 8.67%	69.81M 4,757.42%	29.82M 57.28%	-69.34M 332.52%	124.08M 278.94%	65.69M 47.06%	-103.25M 257.18%	23.52M 122.78%	86.69M 268.50%
cost of revenue	5.65M -	4.55M 19.45%	4.61M 1.33%	4.77M 3.52%
gross profit	-4.33M -	-3.11M 28.05%	65.20M 2,195.29%	25.05M 61.58%	-69.34M 376.81%	124.08M 278.94%	65.69M 47.06%	-103.25M 257.18%	23.52M 122.78%	86.69M 268.50%
selling and marketing expenses
general and administrative expenses	253.60K -	549.50K 116.68%	991.51K 80.44%	880.76K 11.17%	876.76K 0.45%	751.32K 14.31%	844.02K 12.34%	1.08M 27.57%	903.14K 16.12%	1.33M 47.50%
selling general and administrative expenses	253.60K -	549.50K 116.68%	991.51K 80.44%	880.76K 11.17%	876.76K 0.45%	751.32K 14.31%	844.02K 12.34%	1.08M 27.57%	903.14K 16.12%	1.33M 47.50%
research and development expenses
other expenses	143.44K -	129.31K 9.85%	423.33K 227.37%	466.64K 10.23%	259.76K 44.33%	278.66K 7.28%	313.69K 12.57%	275.97K 12.02%
cost and expenses			5.56M -	5.59M 0.58%	1.14M 79.68%	1.03M 9.37%	1.16M 12.40%	1.35M 16.84%	1.17M 13.40%	1.39M 18.55%
operating expenses	397.04K -	678.81K 70.97%	1.26M 84.98%	1.16M 7.83%	1.14M 1.80%	1.03M 9.37%	1.16M 12.40%	1.35M 16.84%	1.17M 13.40%	1.39M 18.55%
interest expense	45.22M -	-8.12M 117.96%	72.43M 991.94%	32.27M 55.45%
ebitda	85.72M -	-20.03M 123.37%	140.99M 803.80%	60.94M 56.78%	-70.48M 215.66%	123.05M 274.60%	64.53M 47.56%	-104.60M 262.10%	22.35M 121.37%
operating income	-4.72M -	-3.79M 19.73%	-3.88M 2.32%	-3.61M 7.00%	-70.48M 1,853.88%	123.05M 274.60%	64.53M 47.56%	-104.60M 262.10%	22.35M 121.37%	85.30M 281.60%
depreciation and amortization	90.44M -	-16.24M 117.96%	144.87M 991.94%	64.54M 55.45%
total other income expenses net	45.22M -	-8.12M 117.96%	72.43M 991.94%	32.27M 55.45%
income before tax	40.50M -	-11.91M 129.41%	68.56M 675.54%	28.66M 58.19%	-70.48M 345.88%	123.05M 274.60%	64.53M 47.56%	-104.60M 262.10%	22.35M 121.37%	85.30M 281.60%
income tax expense			3 -	1 66.67%
net income	40.50M -	-11.91M 129.41%	68.56M 675.54%	28.66M 58.19%	-70.48M 345.88%	123.05M 274.60%	64.53M 47.56%	-104.60M 262.10%	22.35M 121.37%	85.30M 281.60%
weighted average shs out	19.69M -	20.74M 5.37%	21.36M 2.96%	23.30M 9.12%	22.09M 5.19%	23.85M 7.94%	24.26M 1.73%	23.18M 4.45%		28.06M -
weighted average shs out dil	19.69M -	20.74M 5.37%	21.36M 2.96%	23.30M 9.12%	22.09M 5.19%	23.85M 7.94%	24.26M 1.73%	23.18M 4.45%		28.06M -
eps	2.06 -	-0.57 127.67%	3.21 663.16%	1.23 61.68%	-3.19 359.35%	5.16 261.76%	2.66 48.45%	-4.51 269.55%	0 100%	3.04 Infinity%
epsdiluted	2.06 -	-0.57 127.67%	3.21 663.16%	1.23 61.68%	-3.19 359.35%	5.16 261.76%	2.66 48.45%	-4.51 269.55%	0 100%	3.04 Infinity%

All numbers in USD (except ratios and percentages)